• Home
  • Scientific News
    • Structural Heart Disease
    • Coronary Disease
    • Peripheral Vascular Disease
    • Pharmacology
    • Educational Newsletters for Fellows
    • Educational Webinars
    • Other Content
  • Congresses
    • SOLACI-SOCIME 2025 Congress
    • International Congresses
    • SOLACI Congresses
    • Upcoming Events
  • SOLACI Areas
    • Sessions
      • Venezuela Sessions 2025
      • Costa Rica Sessions 2025
      • Previous Sessions
      • About SOLACI Sessions
      • Authorities
      • SOLACI Sessions News
    • ProEducar
      • Educational Newsletters
      • Courses for Fellows
      • The Fellow’s Corner
      • ProEducar Videos and Webinars
      • ProEducar News
    • SOLACI Research
      • 2025 SOLACI Research Grant
      • LATAM-SOLACI Peripheral Registry
      • LATAM-BIF SOLACI Registry
      • Participate in our LATAM-SOLACI Peripheral Registries
      • SOLACI/SIAC Clinical Guidelines TAVR vs SAVR
      • SOLACI-SIAC LM Revascularization Guidelines
      • Authorities
      • Videos and Webinars
      • Research News
    • SOLACI Peripheral
      • LATAM-SOLACI Peripheral Registry
      • Videos and Webinars
      • Authorities
      • SOLACI Peripheral News
    • MIL Group
      • Activities and Initiatives
      • Videos and Webinars
      • History, Mission, and Vision
      • Authorities
      • Mil Group News
    • CHIP LATAM SOLACI
      • Authorities
      • CHIP LATAM SOLACI News
    • SOL SOLACI
      • Authorities
      • SOL SOLACI News
    • Congenital Heart Disease
      • Authorities
      • Congenital Heart Disease News
    • SOLACI Technologists and Nurses
      • Board of Directors
      • Videos and Webinars
      • SOLACI Technologists and Nurses News
  • About SOLACI
    • About us
    • Board of Directors
    • List of members
    • Become A SOLACI Member
    • Update your Info (members)
    • Related Organizations
    • Institutional News
  • Contact
  • Español
  • Português
Search
Logo
Logo
Buscar
Logo
Congreso SOLACI
SOLACI & SBHCI 2026
Bienvenidos al SOLACI & SBHCI 2026
Highlights
Información General
Autoridades
Certificados SOLACI-SOCIME 2025
Facebook
Instagram
Linkedin
Twitter
Youtube
  • Home
  • Scientific News
    • Structural Heart Disease
    • Coronary Disease
    • Peripheral Vascular Disease
    • Pharmacology
    • Educational Newsletters for Fellows
    • Educational Webinars
    • Other Content
  • Congresses
    • SOLACI-SOCIME 2025 Congress
    • International Congresses
    • SOLACI Congresses
    • Upcoming Events
  • SOLACI Areas
    • Sessions
      • Venezuela Sessions 2025
      • Costa Rica Sessions 2025
      • Previous Sessions
      • About SOLACI Sessions
      • Authorities
      • SOLACI Sessions News
    • ProEducar
      • Educational Newsletters
      • Courses for Fellows
      • The Fellow’s Corner
      • ProEducar Videos and Webinars
      • ProEducar News
    • SOLACI Research
      • 2025 SOLACI Research Grant
      • LATAM-SOLACI Peripheral Registry
      • LATAM-BIF SOLACI Registry
      • Participate in our LATAM-SOLACI Peripheral Registries
      • SOLACI/SIAC Clinical Guidelines TAVR vs SAVR
      • SOLACI-SIAC LM Revascularization Guidelines
      • Authorities
      • Videos and Webinars
      • Research News
    • SOLACI Peripheral
      • LATAM-SOLACI Peripheral Registry
      • Videos and Webinars
      • Authorities
      • SOLACI Peripheral News
    • MIL Group
      • Activities and Initiatives
      • Videos and Webinars
      • History, Mission, and Vision
      • Authorities
      • Mil Group News
    • CHIP LATAM SOLACI
      • Authorities
      • CHIP LATAM SOLACI News
    • SOL SOLACI
      • Authorities
      • SOL SOLACI News
    • Congenital Heart Disease
      • Authorities
      • Congenital Heart Disease News
    • SOLACI Technologists and Nurses
      • Board of Directors
      • Videos and Webinars
      • SOLACI Technologists and Nurses News
  • About SOLACI
    • About us
    • Board of Directors
    • List of members
    • Become A SOLACI Member
    • Update your Info (members)
    • Related Organizations
    • Institutional News
  • Contact
  • Español
  • Português
Logo
  • Home
  • Scientific News
    • Structural Heart Disease
    • Coronary Disease
    • Peripheral Vascular Disease
    • Pharmacology
    • Educational Newsletters for Fellows
    • Educational Webinars
    • Other Content
  • Congresses
    • SOLACI-SOCIME 2025 Congress
    • International Congresses
    • SOLACI Congresses
    • Upcoming Events
  • SOLACI Areas
    • Sessions
      • Venezuela Sessions 2025
      • Costa Rica Sessions 2025
      • Previous Sessions
      • About SOLACI Sessions
      • Authorities
      • SOLACI Sessions News
    • ProEducar
      • Educational Newsletters
      • Courses for Fellows
      • The Fellow’s Corner
      • ProEducar Videos and Webinars
      • ProEducar News
    • SOLACI Research
      • 2025 SOLACI Research Grant
      • LATAM-SOLACI Peripheral Registry
      • LATAM-BIF SOLACI Registry
      • Participate in our LATAM-SOLACI Peripheral Registries
      • SOLACI/SIAC Clinical Guidelines TAVR vs SAVR
      • SOLACI-SIAC LM Revascularization Guidelines
      • Authorities
      • Videos and Webinars
      • Research News
    • SOLACI Peripheral
      • LATAM-SOLACI Peripheral Registry
      • Videos and Webinars
      • Authorities
      • SOLACI Peripheral News
    • MIL Group
      • Activities and Initiatives
      • Videos and Webinars
      • History, Mission, and Vision
      • Authorities
      • Mil Group News
    • CHIP LATAM SOLACI
      • Authorities
      • CHIP LATAM SOLACI News
    • SOL SOLACI
      • Authorities
      • SOL SOLACI News
    • Congenital Heart Disease
      • Authorities
      • Congenital Heart Disease News
    • SOLACI Technologists and Nurses
      • Board of Directors
      • Videos and Webinars
      • SOLACI Technologists and Nurses News
  • About SOLACI
    • About us
    • Board of Directors
    • List of members
    • Become A SOLACI Member
    • Update your Info (members)
    • Related Organizations
    • Institutional News
  • Contact
  • Español
  • Português
Home Tags Primary angioplasty

Tag: primary angioplasty

ESC 2019 | Complete: La evidencia definitiva para infartos con múltiples vasos

ESC 2019 | COMPLETE: Definitive Evidence for Infarction with Multivessel Disease

solaci - 5 September, 2019 0
ESC 2019 | CONDI-2ERIC-PPCI: punto final para el pre-acondicionamiento isquémico en angioplastia primaria

ESC 2019 | CONDI-2ERIC-PPCI: Final Blow Against Ischemic Pre-Conditioning in Primary...

solaci - 5 September, 2019 0
DES con polímero bioabsorbible vs Bare Metal Stents en angioplastia primaria

DES with Bioresorbable Polymer vs. Bare Metal Stents in Primary PCI

solaci - 15 July, 2019 0
ACC 2019 | SAFARI: sorpresivamente, el acceso radial no ofrece ventajas en el infarto

ACC 2019 | SAFARI: Unexpectedly, Radial Approach Offers No Benefits In...

solaci - 20 March, 2019 0

Direct Stenting vs. Conventional Angioplasty and Their Interaction with Thrombus Aspiration

solaci - 17 September, 2018 0
MATRIX: Superioridad del acceso radial al año

ESC 2018 | MATRIX: 1-Year Superiority of Transradial Access

solaci - 28 August, 2018 0

EuroPCR 2018 | TRANSIENT trial: What is the best timing for TRANSIENT...

solaci - 1 June, 2018 0
OxAMI-PICSO: oclusión del seno coronario: mejorar la función microvascular y reducir el tamaño del infarto

EuroPCR 2018 | OxAMI-PICSO: Coronary Sinus Occlusion, Improving Microvascular Function and...

solaci - 31 May, 2018 0
SEMPER-FI: el resurgimiento del balón de contrapulsación

EuroPCR 2018 | SEMPER-FI: The Reemergence of the Intra-Aortic Balloon Counterpulsation

solaci - 31 May, 2018 0
EuroPCR 2018 | LEADERS FREE: angioplastias complejas en pacientes con alto riesgo de sangrado

EuroPCR 2018 | LEADERS FREE: Complex Angioplasty in Patients with High Risk...

solaci - 31 May, 2018 0
1...345...7Page 4 of 7
Logo

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Facebook
Instagram
Linkedin
Twitter
Youtube

Últimas Noticias

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Dr. Omar Tupayachi - 28 November, 2025 0
Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 27 November, 2025 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 26 November, 2025 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Noticias Institucionales

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 28 November, 2025 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

solaci - 25 November, 2025 0
Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

solaci - 20 November, 2025 0
The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

Accesos

  • Quiénes somos
  • Comisión Directiva
  • Directorio de Profesionales
  • Asóciese a SOLACI
  • Noticias Institucionales

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad